$ELVN Income Statement | Understand Stock

$ELVN

$41.49 -$0.03 (0.07%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating expenses:
Research and development
General and administrative
Total operating expenses
Gain on Asset Sale

Loss from operations
Other income (expense), net
Interest income
Change in fair value of contingent value right liability
Income tax expense
Net income (loss) attributable to common stockholders—basic and diluted
Net loss per share applicable to common stockholders—basic and diluted
Weighted-average common shares outstanding—basic and diluted
Other expense
Total other income (expense), net
Net income (loss) before income tax provision

Net loss
Accretion of Series B convertible preferred stock
Other comprehensive income (loss):
Net unrealized gains (losses) on marketable securities
Realized gain (loss) on investments

Comprehensive loss
Net loss per share, basic
Net loss per share, diluted
Weighted-average shares outstanding, basic
Weighted-average shares outstanding, diluted

Comments